Strategy for mass production of lytic Staphylococcus aureus bacteriophage pSa-3: contribution of multiplicity of infection and response surface methodology

BACKGROUND: Antibiotic-resistant bacteria have emerged as a serious problem; bacteriophages have, therefore, been proposed as a therapeutic alternative to antibiotics. Several authorities, such as pharmacopeia, FDA, have confirmed their safety, and some bacteriophages are commercially available worl...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Microb Cell Fact
Auteurs principaux: Kim, Sang Guen, Kwon, Jun, Giri, Sib Sankar, Yun, Saekil, Kim, Hyoun Joong, Kim, Sang Wha, Kang, Jung Woo, Lee, Sung Bin, Jung, Won Joon, Park, Se Chang
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2021
Sujets:
Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7923500/
https://ncbi.nlm.nih.gov/pubmed/33653327
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12934-021-01549-8
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires